SCHEMBL4830836

SCHEMBL4830836

Cc1cc(C)c(S(=O)(=O)Nc2ccc(N3CN=c4occc4=C3N)cc2)c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.51
▸ GAA P10253 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ GFER P55789 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ LMNA P02545 3/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4834661 0.90 LMNA (0.44) MAPTGAATSHRPOLBGFER
SCHEMBL4834107 0.86 ALDH1A1 (0.46) GAATSHRALDH1A1LMNANPSR1
SCHEMBL4834223 0.84 CA1 (0.42) MAPTGAAGFERALDH1A1KMT2A
SCHEMBL4834087 0.84 ALDH1A1 (0.47) MAPTGAATSHRPOLBALDH1A1
SCHEMBL4829257 0.84 SGK1 (0.45) MAPTTSHRLMNATP53SMN1; SMN2
SCHEMBL4830867 0.83 LMNA (0.50) MAPTGAAALDH1A1LMNANPSR1
SCHEMBL4826056 0.82 ATM (0.40) MAPTGAAPOLBALDH1A1LMNA
SCHEMBL4831240 0.82 L3MBTL1 (0.40) MAPTTSHRPOLBALDH1A1LMNA
SCHEMBL4833297 0.82 PKM (0.39) MAPTGAATSHRALDH1A1LMNA
SCHEMBL4833946 0.81 KEAP1 (0.46) MAPTPOLBALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US claimed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US claimed
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US disclosed
US-7427623-B2 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof SMITHKLINE BEECHAM CORPORATION (US) 2008-09-23 — — US disclosed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US disclosed
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004142-A1 Chemical compounds TIE1, KDR, TEK MAPT 2499/4885GAA 3329/4885TSHR 3073/4885
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF TIE1, TEK, KDR MAPT 2424/4885GAA 4356/4885TSHR 3243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback